How can I enroll in this study?
_________________________
What
is sudden sensorineural hearing loss?
Study overview
What
is intratympanic steroid therapy? (Flash video)
What
are the entry criteria?
What
if I have limited or no medical insurance?
___________________________
Eight
centers around the U.S. initially participated in this clinical
study, and this has been expanded to eight more centers in the U.S. and Canada - check our list of centers for a list of participating clinics
__________________________
Johns Hopkins Hospital in Baltimore, Maryland,
recruited the first patient for the SSNHL trial on Dec 22, 2004.
A total of 254 patients will be enrolled in this five year
study.
___________________________
information for SSNHL investigators
___________________________
if you are UNABLE to contact one of our study centers, AND you have SSNHL within 2 weeks of the symptoms, you can also contact us at:
hearingresearch@gmail.com
|
Participating
centers in the Sudden Sensorineural Hearing Loss Multicenter
Treatment Trial
SUDDEN SINGLE-SIDED DEAFNESS IS A MEDICAL EMERGENCY AND REQUIRES CARE ASAP
IF YOU HAVE:
1) SUDDEN SINGLE-SIDED DEAFNESS THAT BEGAN LESS THAN 2 WEEKS AGO, AND
2) NEED ADDITIONAL INFORMATION ABOUT HOW TO ENROLL IN OUR STUDY AND
3) YOU ARE UNABLE TO CONTACT ONE OF THE STUDY CENTERS LISTED
YOU CAN ALSO CONTACT US AT:
hearingresearch@gmail.com
California
Iowa
Maryland
New
England
Michigan
New
York
New York University School of Medicine
New York,
New York, 10016, United States
Paul E. Hammerschlag, MD, Principal Investigator
J. Thomas Roland, MD, Sub-Investigator
PLEASE CONTACT:
Dorline Jean, RN, Clinical Coordinator
(212)263-7488
D.Jean@med.nyu.edu
-------------------------------------
New York Eye and Ear Infirmary
New York, NY 10003 USA
Christopher Linstrom, MD - Principal Investigator
George Alexiades, MD - Co-Investigator
Ana Kim, MD - Co-Investigator
Please contact:
Nina Suslina, BS
212-979-4082
nsuslina@nyee.edu
Glorimel Casambre, BS
212-353-5776
gcasambre@nyee.edu
FAX: 212-979-4315
Ohio
|
